558
Views
9
CrossRef citations to date
0
Altmetric
Review Articles

Risk assessment of herbal supplements containing ingredients that are genotoxic and carcinogenic

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 567-579 | Received 07 Aug 2017, Accepted 25 Oct 2019, Published online: 19 Dec 2019

References

  • Abdullah R, Diaz LN, Wesseling S, Rietjens IMCM. 2017. Risk assessment of plant food supplements and other herbal products containing aristolochic acids using the margin of exposure (MOE) approach. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 34:135–144.
  • Alajlouni AM, Al-Malahmeh AJ, Isnaeni FN, Wesseling S, Vervoort J, Rietjens IMCM. 2016. Level of alkenylbenzenes in parsley and dill based teas and associated risk assessment using the margin of exposure approach. J Agric Food Chem. 64:8640–8646.
  • Alajlouni AM, Al-Malahmeh AJ, Wesseling S, Kalli M, Vervoort J, Rietjens IMCM. 2017. Risk assessment of combined exposure to alkenylbenzenes through consumption of plant food supplements containing parsley and dill. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 34:2201–2211.
  • Alhusainy W, Paini A, Punt A, Louisse J, Spenkelink A, Vervoort J, Delatour T, Scholz G, Schilter B, Adams T, et al. 2010. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect. Toxicol Appl Pharmacol. 245:179–190.
  • Alhusainy W, Paini A, van den Berg JHJ, Punt A, Scholz G, Schilter B, van Bladeren PJ, Taylor S, Adams TB, Rietjens IMCM. 2013. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin. Mol Nutr Food Res. 57:1969–1978.
  • Alhusainy W, Williams GM, Jeffrey AM, Iatropoulos MJ, Taylor S, Adams TB, Rietjens IMCM. 2014. The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat. Food Chem Toxicol. 74:28–34.
  • Allgaier C, Franz S. 2015. Risk assessment on the use of herbal medicinal products containing pyrrolizidine alkaloids. Regul Toxicol Pharmacol. 73:494–500.
  • Al-Malahmeh AJ, Alajlouni AM, Ning J, Wesseling S, Vervoort J, Rietjens IMCM. 2017a. Determination and risk assessment of naturally occurring genotoxic and carcinogenic alkenylbenzenes in nutmeg-based plant food supplements. J Appl Toxicol. 37:1254–1264.
  • Al-Malahmeh AJ, Al-Ajlouni AM, Wesseling S, Vervoort J, Rietjens IMCM. 2017b. Determination and risk assessment of naturally occurring genotoxic and carcinogenic alkenylbenzenes in basil-containing sauce of pesto. Toxicol Rep. 4:1–8.
  • Al-Subeihi AAA, Alhusainy W, Paini A, Punt A, Vervoort J, van Bladeren PJ, Rietjens IMCM. 2013. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling. Food Chem Toxicol. 59:564–571.
  • Arlt VM, Stiborova M, Schmeiser HH. 2002. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis. 17:265–277.
  • Asano N, Ikeda K, Kasahara M, Arai Y, Kizu H. 2004. Glycosidase-inhibiting pyrrolidines and pyrrolizidines with a long side chain in Scilla peruviana. J Nat Prod. 67:846–850.
  • Barnes KA, Ball L, Desbrow B, Alsharairi N, Ahmed F. 2016. Consumption and reasons for use of dietary supplements in an Australian university population. Nutrition. 32:524–530.
  • Bieler CA, Stiborova M, Wiessler M, Cosyns J, De Strihou CVY, Schmeiser HH. 1997. Analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy. Carcinogenisis. 18:1063–1067.
  • Boberg EW, Miller EC, Miller JA, Poland A, Liem A. 1983. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1′-hydroxysafrole in mouse liver. Cancer Res. 43:5163–5173.
  • Bodi D, Ronczka S, Gottschalk C, Behr N, Skibba A, Wagner M, Lahrssen-Wiederholt M, Preiss-Weigert A, These A. 2014. Determination of pyrrolizidine alkaloids in tea, herbal drugs and honey. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 31:1886.
  • Boonpawa R, Spenkelink A, Punt A, Rietjens IMCM. 2017. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans. Mol Nutr Food Res. 61. DOI:10.1002/mnfr.201600894
  • But PPH, Ma SC. 1999. Chinese-herb nephropathy. Lancet. 354:1731–1732.
  • Chen T, Mei N, Fu PP. 2010. Genotoxicity of pyrrolizidine alkaloids. J Appl Toxicol. 30:183–196.
  • Chen L, Mulder PPJ, Louisse J, Peijnenburg A, Wesseling S, Rietjens IMCM. 2017. Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements. Regul Toxicol Pharmacol. 86:292–302.
  • Cheung TP, Xue C, Leung K, Chan K, Li CG. 2006. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products – a consequence of inappropriate nomenclature and imprecise labelling? Clin Toxicol. 44:371–378.
  • Cosyns J. 2003. Aristolochic acid and “Chinese herbs nephropathy” a review of the evidence to date. Drug Saf. 26:33–48.
  • Crump KS, Hoel DG, Langley CH, Peto R. 1976. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36:2973–2979.
  • Dawidowicz AL, Dybowski MP. 2012. Determination of myristicin in commonly spices applying SPE/GC. Food Chem Toxicol. 50:2362–2367.
  • Debelle F, Nortier J, De Prez E, Garbar CH, Vienne AR, Salmon IJ, Deschodt-Lanckman MM, Vanherweghem J. 2002. Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol. 13:431–436.
  • Dreger M, Stanisławska M, Krajewska-Patan A, Mielcarek S, Mikołajczak PŁ. 2009. Pyrrolizidine alkaloids – chemistry, biosynthesis, pathway, toxicity, safety and perspectives of medicinal usage. Herba Pol. 55:21.
  • Dusemund B, Nowak N, Sommerfeld C, Lindtner O, Schäfer B, Lampen A. 2018. Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin. Food Chem Toxicol. 115:63–72.
  • EFSA. 2005. Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of sub-stances which are both genotoxic and carcinogenic. EFSA J. 282:1–31.
  • EFSA. 2011. Scientific opinion on pyrrolizidine alkaloids in food and feed. EFSA J. 9:2406.
  • Egan B, Hodgkins C, Shepherd R, Timotijevic L, Raats M. 2011. An overview of consumer attitudes and beliefs about plant food supplements. Food Funct. 2:747–752.
  • Elvin-Lewis M. 2001. Should we be concerned about herbal remedies. J Ethnopharmacol. 75:141–164.
  • European Commission. 2008. REGULATION (EC) No 1334/2008 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L. 354: 34–50.
  • Farzaei MH, Abbasabadi Z, Ardekani MRS, Rahimi R, Farzaei, F. 2013. Parsley: a review of ethnopharmacology, phytochemistry and biological activities. J Tradit Chinese Med. 33:815–826.
  • European Medicines Agency. 2014. Public statement on the use of herbal medicinal products containing estragole. EMA/HMPC/137212/2005 Rev 1: 1–19.
  • Felter SP, Conolly RB, Bercu JP, Bolger PM, Boobis AR, Bos PMJ, Carthew P, Doerrer NG, Goodman JI, Harrouk WA, et al. 2011. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens. Crit Rev Toxicol. 41:507–544.
  • Franz C, Chizzola R, Novak J, Sponza S. 2011. Botanical species being used for manufacturing plant food supplements (PFS) and related products in the EU member states and selected third countries. Food Funct. 2:720–730.
  • Garcia-Alvarez A, Egan B, De Klein S, Dima L, Maggi FM, Isoniemi M, Ribas-Barba L, Raats MM, Meissner EM, Badea M, et al. 2014. Usage of plant food supplements across six European countries: findings from the PlantLIBRA Consumer Survey. PLoS One. 9:e92265–18.
  • Gaylor DW. 2000. The use of Haber’s Law in standard setting and risk assessment. Toxicology. 149:17–19.
  • Gori L, Gallo E, Mascherini V, Mugelli A, Vannacci A, Firenzuoli F. 2012. Can estragole in fennel seed decoctions really be considered a danger for human health? A fennel safety update. Evid Based Complement Alternat Med. 2012:1.
  • Heinrich M. 2004. Medicinal plants of the world. An illustrated scientific guide to important medicinal plants and their uses. J Ethnopharmacol. 91:371–373.
  • Hirono I, Mori H, Haga M. 1978. Carcinogenic Activity of Symphytum officinale. J Natl Cancer Inst. 61:865–869.
  • Hsieh S, Huang M, Lin B, Chang H. 2006. Determination of aristolochic acid in Chinese herbal medicine by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr A. 1105:127–134.
  • Huang C, Tseng M, Lin J. 2005. Analyzing aristolochic acids in Chinese herbal preparations using LC/MS/MS. J Food Drug Anal. 13:125–131.
  • Keute V. 2014. Health effects of alkaloids from African medicinal plants. In: Kuete V, editor. Toxicological survey of African medicinal plants. London: Elsevier; p. 611–626.
  • Khanbabaee K, Ree TV. 2001. Tannins: classification and definition. Nat Prod Rep. 18:641–649.
  • Knutsen HK, Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S, Cottrill B, Dinovi M, Edler L, Grasl‐Kraupp B, et al. 2017. Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements. EFSA J. 15:4908.
  • Koleva II, van Beek TA, Soffers AEMF, Dusemund B, Rietjens IMCM. 2012. Alkaloids in the human food chain–natural occurrence and possible adverse effects. Mol Nutr Food Res. 56:30–52.
  • Kuracki M, Miljkovic D, Živojinov S, Čapo I, Lalosevic D. 2013. Aristolochic acid nephropathy: a model of nephrotoxic lesion. Biol Serbica. 35:57–61.
  • Lee T, Wu M, Deng J, Hwang D. 2002. High-performance liquid chromatographic determination for aristolochic acid in medicinal plants and slimming products. J Chromatogr B. 766:169–174.
  • Lieberman HR, Marriott BP, Williams C, Judelson DA, Glickman EL, Geiselman PJ, Dotson L, Mahoney CR. 2015. Patterns of dietary supplement use among college students. Clin Nutr. 34:976–985.
  • Low TY, Wong KO, Yap ALL, De Haan LHJ, Rietjens IMCM. 2017. The regulatory framework across international jurisdictions for risks associated with consumption of botanical food supplements. Compr Rev Food Sci Food Saf. 16:821–834.
  • Mahomoodally MF, Muthoorah LD. 2014. Ethnopharmacological survey of natural remedies used by the Chinese community in Mauritius. Asian Pac J Trop Biomed. 4:387–399.
  • Martati E, Boonpawa R, van den Berg JHJ, Paini A, Spenkelink A, Punt A, Vervoort J, van Bladeren PJ, Rietjens IMCM. 2014. Malabaricone C-containing mace extract inhibits safrole bioactivation and DNA adduct formation both in vitro and in vivo. Food Chem Toxicol. 66:373–384.
  • Martena MJ, Van der Wielen JCA, Van der Laak LFJ, Konings EJM, De Groot HN, Rietjens IMCM. 2007. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal Bioanal Chem. 389:263–275.
  • Merz KH, Schrenk D. 2016. Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines. Toxicol Lett. 263:44–57.
  • Michl J, Ingrouille MJ, Simmonds MSJ, Heinrich M. 2014. Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep. 31:676–693.
  • Mori H, Sugie S, Yoshimi N, Asada Y, Furuya T, Williams GM. 1985. Genotoxicity of a variety of pyrrolizidine alkaloids in the hepatocyte primary culture-DNA repair test using rat, mouse, and hamster hepatocytes. Cancer Res. 45:3125–3129.
  • Mulder PPJ, López Sanchez P, These A, Preiss-Weigert A, Castellari M. 2015. Occurrence of Pyrrolizidine Alkaloids in food. EFSA. EN-859:1–114.
  • Mulder PPJ, López P, Castelari M, Bodi D, Ronczka S, Preiss-Weigert A, These A. 2018. Occurrence of pyrrolizidine alkaloids in animal- and plant-derived food: results of a survey across Europe. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 35:118–133.
  • Ning J, Cui XY, Kong XN, Tang YF, Wulandari R, Chen L, Wesseling S, Rietjens IMCM. 2018. Risk assessment of genotoxic and carcinogenic alkenylbenzenes in botanical containing products present on the Chinese market. Food Chem Toxicol. 115:344–357.
  • Paini A, Punt A, Viton F, Scholz G, Delatour T, Marin-Kuan M, Schilter B, van Bladeren PJ, Rietjens IMCM. 2010. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes. Toxicol Appl Pharmacol. 245:57–66.
  • Paini A, Scholz G, Marin-Kuan M, Schilter B, O'Brien J, van Bladeren PJ, Rietjens IMCM. 2011. Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays. Mutagenesis. 26:605–618.
  • Popat A, Shear NH, Malkiewicz I, Stewart MJ, Steenkamp V, Thomson S, Neuman MG. 2001. The toxicity of Callilepis laureola, a South African traditional herbal medicine. Clin Biochem 34:229–236.
  • Pozdzik AA, Salmon IJ, Debelle FD, Decaestecker C, Van den Branden C, Verbeelen D, Deschodt-Lanckman MM, Vanherweghem JL, Nortier JL. 2008. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int. 73:595–607.
  • Prinsloo G, Nogemane N, Street R. 2018. The use of plants containing genotoxic carcinogens as foods and medicine. Food Chem Toxicol. 116:27–39.
  • Raffo A, D’Aloise A, Magri AL, Leclercq C. 2013. Quantitation of tr-cinnamaldehyde, safrole and myristicin in cola-flavoured soft drinks to improve the assessment of their dietary exposure. Food Chem Toxicol. 59:626–635.
  • Raffo A, Nicoli S, Leclercq C. 2011. Quantification of estragole in fennel herbal teas: implications on the assessment of dietary exposure to estragole. Food Chem Toxicol. 49:370–375.
  • Rather MA, Dar BA, Sofi SN, Bhat BA, Qurishi MA. 2016. Foeniculum vulgare: a comprehensive review of its traditional use, phytochemistry, pharmacology and safety. Arab J Chem. 9:S1574–S1583.
  • Rietjens IMCM, Boersma MG, Van der Woude H, Jeurissen SMF, Schutte ME, Alink GM. 2005. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat Res. 574:124–138.
  • Rietjens IMCM, Cohen SM, Fukushima S, Gooderham NJ, Hecht S, Marnett LJ, Smith RL, Adams TB, Bastaki M, Harman CG, Taylor SV. 2014. Impact of structural and metabolic variations on the toxicity and carcinogenicity of hydroxy- and alkoxy-substituted allyl- and propenylbenzenes. Chem Res Toxicol. 27:1092–1103.
  • Rietjens IMCM, Punt A, Schilter B, Scholz G, Delatour T, van Bladeren PJ. 2010. In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment. Mol Nutr Food Res. 54:195–207.
  • Rietjens IMCM, Slob W, Galli C, Silano V. 2008. Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: emerging issues. Toxicol Lett. 180:131–136.
  • Rietjens IMCM, Tyrakowska B, van den Berg SJPL, Soffers AEMF, Punt A. 2015. Matrix-derived combination effects influencing absorption, distribution, metabolism and excretion (ADME) of food-borne toxic compounds: implications for risk assessment. Toxicol Res. 4:23–35.
  • Robertson J, Stevens K. 2017. Pyrrolizidine alkaloids: occurrence, biology, and chemical synthesis. Nat Prod Rep. 34:62–89.
  • Schaneberg BT, Khan IA. 2004. Analysis of products suspected of containing Aristolochia or Asarum species. J Ethnopharmacol. 94:245–249.
  • Selzer G, Parker RGF. 1951. Senecio poisoning exhibiting as Chiari’s syndrome. A report on twelve cases. Am J Pathol. 27:165–185.
  • Shand AW, Walls M, Chatterjee R, Nassar N, Khambalia AZ. 2016. Dietary vitamin, mineral and herbal supplement use: a cross-sectional survey of before and during pregnancy use in Sydney, Australia. Aust NZ J Obstet Gynaecol. 56:154–161.
  • Shibutani S, Bonala RR, Rosenquist T, Rieger R, Suzuki N, Johnson F, Miller F, Grollman AP. 2010. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents. Int J Cancer. 127:1021–1027.
  • Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP. 2007. Selective toxicity of aristolochic acids I and II. Drug Metab Dispos. 35:1217–1222.
  • Siruguri V, Bhat RV. 2015. Assessing intake of spices by pattern of spice use, frequency of consumption and portion size of spices consumed from routinely prepared dishes in southern India. Nutr J. 14:1–9.
  • Smith RL, Adams TB, Doull J, Feron VJ, Goodman JI, Marnett LJ, Portoghese PS, Waddell WJ, Wagner BM, Rogers AE, et al. 2002. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances — methyl eugenol and estragole. Food Chem Toxicol. 40:851–870.
  • Stanfill SB, Ashley DL. 1999. Solid phase microextraction of alkenylbenzenes and other flavor-related compounds from tobacco for analysis by selected ion monitoring gas chromatography-mass spectrometry. J Chromatogr A. 858:79–89.
  • Steenkamp V, Stewart MJ, van der Merwe S, Zuckerman M, Crowther NJ. 2001. The effect of Senecio latifolius a plant used as a South African traditional medicine, on a human hepatoma cell line. J Ethnopharmacol. 78:51–58.
  • Stewart MJ, Steenkamp V. 2001. Pyrrolizidine poisoning: a neglected area in human toxicology pyrrolizidine poisoning. Ther Drug Monit. 23:698–708.
  • Street RA. 2012. Heavy metals in medicinal plant products — an African perspective. South African J Bot. 82:67–74.
  • Street RA, Stirk WA, Van Staden J. 2008. South African traditional medicinal plant trade-Challenges in regulating quality, safety and efficacy. J Ethnopharmacol. 119:705–710.
  • Suparmi S, Widiastuti D, Wesseling S, Rietjens IMCM. 2018. Natural occurrence of genotoxic and carcinogenic alkenylbenzenes in Indonesian jamu and evaluation of consumer risks. Food Chem Toxicol. 118:53–67.
  • Taylor DL, Nash R, Fellows LE, Kang MS, Tyms AS. 1992. Naturally occurring pyrrolizidines: inhibition of ex-glucosidase 1 and anti-HIV activity of one stereoisomer. Antivir Chem Chemother. 3:273–277.
  • Vaclavik L, Krynitsky AJ, Rader JI. 2014. Quantification of aristolochic acids I and II in herbal dietary supplements by ultra-high- performance liquid chromatography – multistage fragmentation mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 31:784–791.
  • Van den Berg SJPL, Restani P, Boersma MG, Delmulle L, Rietjens IMCM. 2011a. Levels of genotoxic and carcinogenic ingredients in plant food supplements and associated risk assessment. FNS. 2:989–1010.
  • Van den Berg SJPL, Serra-Majem L, Coppens P, Rietjens IMCM. 2011b. Safety assessment of plant food supplements (PFS). Food Funct. 2:760–768.
  • Vargas-Murga L, Garcia-Alvarez A, Roman-Vinas B, Ngo J, Ribas-Barba L, van den Berg SJPL, Williamson G, Serra-Majem L. 2011. Plant food supplement (PFS) market structure in EC Member States, methods and techniques for the assessment of individual PFS intake. Food Funct. 2:731–739.
  • Wang Y, Chan W. 2014. Determination of aristolochic acids by high-performance liquid chromatography with fluorescence detection. J Agric Food Chem. 62:5859–5864.
  • Watt HE. 1909. The alkaloids of Senecio latifolius. J Chem Soc. 95:466–477.
  • WHO. 2011. Discussion paper on pyrrolizidine alkaloids. Joint FAO/WHO food standards programme, Codex committee on contaminants in foods 5th session. Codex alimentarius commission. REP11/EC:80-83.
  • Willmot F, Robertson G. 1920. Senecio disease, or cirrhosis of the liver due to Senecio poisoning. Lancet. 196:848–849.
  • Wiseman RW, Miller EC, Miller JA, Liem A. 1987. Structure-activity studies of the hepatocarcinogenicities of alkenylbenzene derivatives related to estragole and safrole on administration to preweanling male C57BL/6J x C3H/HeJ F1 mice. Cancer Res. 47:2275–2283.
  • Yang H, Chen P, Wang J. 2014. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. Biomed Res Int. 2014:1.
  • Zuckerman M, Steenkamp V, Stewart MJ. 2002. Hepatic veno-occlusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol. 55:676–679.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.